How Much Growth Is Anticipated In The Glucometer Market Size From 2026 To 2035?
The glucometer market size has grown rapidly in recent years. It will grow from $15.43 billion in 2025 to $17.25 billion in 2026 at a compound annual growth rate (CAGR) of 11.8%. The growth in the historic period can be attributed to increasing prevalence of diabetes globally, rising awareness of blood glucose monitoring, expansion of home healthcare adoption, availability of affordable glucometers, growth of chronic disease management programs.
The glucometer market size is expected to see rapid growth in the next few years. It will grow to $26.77 billion in 2030 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to increasing adoption of ai-enabled glucose monitoring, rising demand for wearable health devices, expansion of digital diabetes management platforms, growing focus on personalized diabetes care, increasing integration with telehealth services. Major trends in the forecast period include increasing adoption of continuous glucose monitoring systems, rising demand for non-invasive glucose monitoring, growing integration of mobile health applications, expansion of home-based diabetes monitoring solutions, enhanced focus on real-time data analytics.
Claim Your Free Report Sample Today:
What Key Drivers Are Primarily Contributing To The Growth Of The Glucometer Market?
The increase in the prevalence of diabetes is driving the demand for the glucometer market going forward. Diabetes is a long-lasting metabolic condition. It is characterized by high blood glucose (also known as blood sugar) levels, which, over time, cause significant harm to the heart, blood vessels, eyes, kidneys, and nerves. People who are suffering from diabetes use a glucometer to monitor their blood glucose levels. Therefore, with an increase in diabetes among people, the demand for glucometers is also increasing. For instance, in June 2024, according to the National Health Service, a UK-based government department, in 2023, the NHS identified over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This represents a significant increase compared to 3,065,825 in 2022. Therefore, the increase in the prevalence of diabetes drives the glucometer market.
What Are The Essential Segmentation Layers Examined Within The Glucometer Market?
The glucometer market covered in this report is segmented –
1) By Product: Continuous Glucose Monitoring Devices, Self-Monitoring Blood Glucose System
2) By Technique: Invasive, Non-Invasive
3) By Distribution Channel: Institutional Sales, Hospitals, Clinics, Retail Sales, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Continuous Glucose Monitoring Devices: Real-Time CGM Systems, Flash Glucose Monitoring Systems
2) By Self-Monitoring Blood Glucose System: Blood Glucose Meters, Test Strips, Lancets
Which Strategic Trends Are Likely To Impact Competitive Positioning In The Glucometer Market?
Major companies operating in the glucometer market are focused on developing built-in cellular technology to enhance real-time data transmission and remote monitoring capabilities. Built-in cellular technology is the integration of cellular communication capabilities directly into a device, allowing it to connect to mobile networks without needing a separate module or external device. For instance, in May 2024, Smart Meter, a US-based monitoring device company, launched iGlucose Plus for enhanced diabetes management. This technology enables devices to send and receive data via cellular networks, similar to how smartphones operate, thereby facilitating timely access to health information, improving patient engagement, and allowing healthcare providers to monitor and manage patients' glucose levels more effectively, ultimately leading to better health outcomes and more personalized care.
Who Are The Prominent Industry Participants Shaping The Glucometer Market?
Major companies operating in the glucometer market are Johnson & Johnson Services Inc., Bayer AG, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Medtronic plc., Arkray Inc., Omron Corporation, Dexcom Inc., Bionime Corporation, LifeScan Inc., NOVA Biomedical, Sinocare Inc., TaiDoc Technology Corporation, i-SENS Inc., EKF Diagnostics Holdings plc, ForaCare Inc., LabStyle Innovations Corp., Acon Laboratories Inc., Ascensia Diabetes Care Holdings AG, Ypsomed AG, Medtrum Health Inc., Cellnovo Group
Get Your In-Depth Glucometer Market Report Now:
Which Regions Are Anticipated To Post The Highest CAGR In The Glucometer Market?
North America was the largest region in the glucometer market in 2025. The regions covered in the glucometer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: Market Research Reports
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment